BPMZW - 122A, LITHO DEVELOPER PART A
- MSDS: BPMZW
- Manufacturer: POLYCHROME CORP
- Product Name: 122A, LITHO DEVELOPER PART A
- National Stock Number: 6850-00N032305
Product Identification
Product ID:122A, LITHO DEVELOPER PART A
MSDS Date:04/15/1986
FSC:6850
NIIN:00N032305
Kit Part:Y
MSDS Number: BPMZW
Responsible Party
YONKERS, NY 10702
US
Emergency Phone: 914-965-8800
Info Phone: 914-965-8800
Preparer: R.J.G.
Cage: 86550
Contractor
Telephone: 201-531-5814
Cage: 86550
Ingredients
METHANESULFONIC ACID, HYDROXY-, SODIUM SALT; (SODIUM
CAS: 870-72-4
RTECS: PB2200000
Fraction By Weight: 54%
HYDROQUINONE (SARA III)
CAS: 123-31-9
RTECS: MX3500000
Fraction By Weight: 11.5%
OSHA PEL 2 MG/M3
ACGIH TLV: 2 MG/M3
EPA Report Quantity: 1 LB
DOT Report Quantity: 1 LB
POTASSIUM HYDROXIDE (SARA III)
CAS: 1310-58-3
RTECS: TT2100000
Fraction By Weight: 0.9%
OSHA PEL 2 MG/M3 STEL,C
ACGIH TLV: 2 MG/M3 STEL,C
EPA Report Quantity: 1000 LBS
DOT Report Quantity: 1000 LBS
Hazards
LD50 LC50 Mixture:NONE SPECIFIED BY MANUFACTURER.
Routes of Entry: Inhalation:NO Skin:NO Ingestion:NO
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:PURE HYDROQUINONE IS A SEVERE SKIN
IRRITANT; CAUSES INFLAMMATION OF EYES. EXPOSURE TO EXPERIMENTAL
ANIMALS HAS RESULTED IN DAMAGE TO REPRODUCTIVE ORGANS. FORMALDEHYDE
HAS BEEN SHOWN TO CAUSE CANCER OF THE NASAL PASSAGES IN
EXPERIMENTAL ANIMALS.
Explanation of Carcinogenicity:NOT RELEVANT.
Effects of Overexposure:SEE HEALTH HAZARDS.
Medical Cond Aggravated by Exposure:NONE SPECIFIED BY MANUFACTURER.
First Aid
First Aid:EYE:FLUSH WITH WATER FOR A MINIMUM OF 15 MINUTES AND GET MD.
SKIN:WASH WITH SOAP & WATER, REMOVE CONTAMINATED CLOTHES. INGEST:DO
NOT INDUCE VOMITING. CALL MD IMMEDIATELY. INHAL:MOVE TO FRESH AIR.
CALL MD IMMEDIATELY.
Fire Fighting
Flash Point:NON-FLAMMABLE
Extinguishing Media:FOAM, CO2.
Fire Fighting Procedures:WEAR NIOSH/MSHA APPROVED SCBA & FULL
PROTECTIVE EQUIPMENT .
Unusual Fire/Explosion Hazard:THERMAL DECOMPOSITION CAN RELEASE TOXIC
FUMES.
Accidental Release
Spill Release Procedures:CONTAIN SPILL WITH ABSORBENT MATERIAL. SWEEP
UP AND DISPOSE OF AS NOTED.
Neutralizing Agent:NONE SPECIFIED BY MANUFACTURER.
Handling
Handling and Storage Precautions:STORE ABOVE 50F (10C) BUT AVOID DIRECT
HEAT. HIGH TEMPERATURES MAY CAUSE CHEMICAL DETERIORATION.
Other Precautions:KEEP OUT OF REACH OF CHILDREN.
Exposure Controls
Respiratory Protection:NIOSH/MSHA APPROVED RESPIRATOR APPROPRIATE FOR
EXPOSURE OF CONCERN .
Ventilation:LOCAL EXHAUST DESIRABLE.
Protective Gloves:RUBBER GLOVES.
Eye Protection:CHEM WORK GOGG/FULL LENGTH FSHLD .
Other Protective Equipment:EMERGENCY EYE WASH AND DELUGE SHOWER .
Work Hygienic Practices:NONE SPECIFIED BY MANUFACTURER.
Supplemental Safety and Health
KEY1;T6.HMIS(LEVIEN) NOTES THAT HYDROQUINONE IS REGULATED BY DOT AS A
POISON 6.1.
Chemical Properties
HCC:C2
Spec Gravity:1.259 @ 70F
Solubility in Water:COMPLETE
Appearance and Odor:COLORLESS LIQUID WITH MILD ODOR
Percent Volatiles by Volume:54(WT)
Stability
Stability Indicator/Materials to Avoid:YES
STRONG ACIDS.
Stability Condition to Avoid:NOT APPLICABLE.
Hazardous Decomposition Products:MAY LIBERATE SOX.
Disposal
Waste Disposal Methods:MUST BE DISPOSED OF IN ACCORDANCE WITH LOCAL,
STATE AND FEDERAL REGULATIONS.
Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.